These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34878728)

  • 21. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
    Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
    Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.
    Wang M; Hou S; Wei Y; Li D; Lin J
    PLoS Comput Biol; 2021 Mar; 17(3):e1008821. PubMed ID: 33739970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A
    Zhang M; Fan S; Zhou X; Xie F; Li S; Zhong W
    Eur J Med Chem; 2019 Oct; 179():310-324. PubMed ID: 31255928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
    Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imidazo[1,2-α]pyridines possess adenosine A
    Lefin R; van der Walt MM; Milne PJ; Terre'Blanche G
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3963-3967. PubMed ID: 28789895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
    Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
    Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
    Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
    Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A
    Nkomba G; Terre'Blanche G; Janse van Rensburg HD; Legoabe LJ
    Med Chem Res; 2022; 31(8):1277-1297. PubMed ID: 35634433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A
    Renk DR; Skraban M; Bier D; Schulze A; Wabbals E; Wedekind F; Neumaier F; Neumaier B; Holschbach M
    Eur J Med Chem; 2021 Mar; 214():113214. PubMed ID: 33548636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-[9-(ortho-fluorobenzyl)-2-phenyl-8-azapurin-6-yl]-amides as potent and selective ligands for A₁ adenosine receptors.
    Borghini A; Pietra D; Leonardi M; Giorgi I; Bianucci AM
    Chem Biol Drug Des; 2013 Jul; 82(1):22-38. PubMed ID: 23480235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
    Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the basis of sex: male vs. female rat adenosine A
    Janse van Rensburg HD; Terre'Blanche G; Van der Walt MM
    BMC Res Notes; 2023 Aug; 16(1):165. PubMed ID: 37563689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.
    Lim HK; Chen J; Sensenhauser C; Cook K; Preston R; Thomas T; Shook B; Jackson PF; Rassnick S; Rhodes K; Gopaul V; Salter R; Silva J; Evans DC
    Chem Res Toxicol; 2011 Jul; 24(7):1012-30. PubMed ID: 21667953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
    Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
    J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson's Disease.
    Subair TI; Soremekun OS; Olotu FA; Soliman MES
    Cell Biochem Biophys; 2021 Mar; 79(1):25-36. PubMed ID: 33222095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
    Giunta S; Andriolo V; Castorina A
    Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.